Medidata, a Dassault Systèmes brand, has announced a strategic partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others. The partnership aims to deliver an improved experience for customers through faster trial starts and optimal rater experiences, providing a streamlined rater journey through a single mobile device app and a comprehensive suite of data quality assurance solutions for CNS assessments.